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Multiple studies have shown throughout the past 10+ years that grain sorghum (GS) lipid
extract protects against high plasma and hepatic cholesterol and, to a lesser degree, positively
modulate the gut microbiota in response to a high fat (HF) diet. However, the impact of GS lipids
on intestinal stress induced by such a diet remains largely unknown. The objective of this project
was to determine the ability of GS crude lipid (GS-CL) obtained from the surface of GS whole
kernel to protect energy metabolism and short chain fatty acid (SCFA) profile produced by the
gut microbiome that may be negatively affected by a HF diet. If left unchecked, such impacts can
lead to hypoxia or inflammation and thereby other chronic conditions. In our study, male
hamsters were fed with either a low fat control diet, a HF diet or a HF diet supplemented with 1,
3, 5% (w/w) GS-CL for four weeks. The hamsters were then euthanized and the large intestine
obtained and analyzed using targeted metabolomics. Analysis of central carbon metabolites
showed that the HF diet impaired energy generation and disrupted cellular redox balance. A
significant increase of many intermediates of glycolysis (particularly glyceraldehyde-3phosphate, glycerate-3-phosphate and phosphoenolpyruvate) and tricarboxylic acid (TCA) cycle
(particularly succinate, fumarate and malate) occurred in response to a HF influence, while nearly
all amino acids were significantly lower compared to the low fat diet. The GS-CL supplements
were able to maintain energy levels in the large intestine, especially the 1 and 3% but were not
able to rebalance redox equilibrium completely. Moreover, multivariant analysis including
orthogonal-partial least squares-discrimination analysis (OPLS-DA) demonstrated that the GS-CL

supplements were able to gradually maintain the HF affected metabolites to levels trending or
comparable to the control level, with 3% supplement being the optimal diet in this regard. In
general, the data indicated that the GS-CL supplements slowed down the gluconeogenesis and
anaplerosis from pyruvate and amino acids, which in turn mitigated the accumulation of
glycolysis and TCA intermediates in a dose-depended manner. In addition, the GS-CL
supplements positively affected the short chain fatty acid (SCFA) produced by large intestine
microbiome, with the 3% diet again exerting the optimal protection, against HF induced changes
in SCFA profile followed by 1% supplement. Synergistic interaction among various components
in GS-CL (such as the characterized phytosterols and policosanols) may be responsible for some
of the metabolic responses as the effects of GS-CL is optimal compared to that reported of the GS
oil or wax fraction alone. This study is the first to provide whole-scale impact of GS-CL on
cellular energy and central carbon metabolism using a combined approach of metabolomics and
multivariant analysis, which effectively demonstrate the potentials of GS-CL as a supplement to
prevent or contain chronic metabolic diseases.
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1.
I.

Literature review
Introduction to grain sorghum (GS)
Sorghum (Sorghum bicolor (L.) Moench), in the form of a grain, forage or sugar crop, is

the fifth most important cereal in the world succeeded only by wheat, rice, maize and barley
(Althwab, Carr, Weller, Dweikat, & Schlegel, 2015). Currently, sorghum is widely cultivated in
more than 30 countries due to its tolerance to temperature and moist fluctuations, thereby
providing food for over 500 million people (Rooney, et al., 2010). For the United States, grain
sorghum (GS) acreage has ranged from 15 to 18 million acres per year during the past 25 years
(Carter, et al., 2016), which is slightly greater than land dedicated to oat and barley production. In
2011, the U.S was the No. 1 exporter and the No. 2 producer (behind Nigeria) of GS with Kansas,
Arkansas, Nebraska, Colorado and Missouri being the primary GS growers among the 21 states
that produce sorghum according to the U.S. Department of Agriculture (2016).
Yet, GS has been mainly used as animal feeds in the U.S., but more recently interest has
been growing in employing GS as a source for biofuel production (Wang, Weller, & Hwang,
2005). This lack of GS consumption in the U.S. is regrettable as GS contains a unique
phytochemical profile, including phenolic acids, condensed tannins, anthocyanins, policosanols
and phytosterols (Awika & Rooney, 2004). Indeed, numerous studies on these compounds using
both an in vitro and in vivo approaches have shown their antioxidant and anti-inflammatory
effects as well as their health benefiting properties on weight control, glycemic control and gut
microbiota as will be discussed in the next sections of this chapter.

A. Composition and potential health benefits of grain sorghum
Grain sorghum provides a rich source of health promoting agents (nutraceuticals) for the
human diet. The main components present in GS include starch (~75%), protein (~12%), lipids
(~4%), fiber (~7%) and several minerals and vitamins (Althwab, Carr, Weller, Dweikat, &
Schlegel, 2015) (Stefoska-Needham, Beck, Johnson, & Tapsell, 2015). Additionally, GS
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possesses a unique phytochemical profile, including ample types of phytosterols, policosanols
and phenolic compounds, which are often considered the components responsible for the many
health benefits associated with GS (Awika & Rooney, 2004) (de Morais Cardoso, Pinheiro,
Martino, & Pinheiro-Sant'Ana, 2017).
i.

Antioxidant
Grain sorghum exhibits significantly antioxidant activity as reported throughout the

literature. For example, feeding high tannin sorghum to rats reduced markers of protein oxidation
in the muscle without affecting animal growth (Larrain, Richards, Schaefer, & Reed, 2007).
During colon carcinogenesis, rats fed a black sorghum bran diet presented with increased activity
of colon-based superoxide dismutase (SOD), while rats fed white sorghum bran exhibited
elevated catalase (CAT) activity. These results indicate that the sorghum diet is able to increase
key endogenous antioxidant enzymes to protect against oxidative stress (Lewis, et al., 2008).
Oboh et al. (2010) also confirmed the antioxidant properties of sorghum by demonstrating the
neuroprotective effect of a red dye fraction obtained from a sorghum extract against
cyclophosphamide-induced oxidative stress using a rat clinical model. The protective effect was
attributed to the antioxidant activities exerted by the high phenolic components present in the red
dye. In addition, cisplatin-induced nephrotoxicity and hepatotoxicity were remediated by a
sorghum straw and a leaf sheath dye supplement, respectively, which occurred by reversing
elevated plasma, kidney and liver antioxidant indices (Ademiluyi, Oboh, Agbebi, & Oyeleye,
2014). Moreover, Ajiboye et al. (2013) demonstrated that a sorghum phenolic rich extract
protected rat microsomes against diethylnitrosamine (DEN)-induced redox imbalance by
significantly attenuating a DEN-mediated decrease in the activities of redox oxygen species
(ROS) detoxifying enzymes. Recently, a human clinical trial using healthy subjects studied the
antioxidative effect of consuming pasta containing sorghum flour. The sorghum treated group
presented with significantly higher plasma polyphenols, antioxidant capacity, SOD activity and
lower protein carbonyl levels compared to control group, indicating an enhanced antioxidant
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status and improved markers of oxidative stress (Khan, Yousif, Johnson, & Gamlath, 2015).
Lastly, Cruz et al. (2015) showed that a sorghum kafirin extract resulted in higher proportion of
α-kafirin monomers and hydrophobic amino acid content, which in turn has been linked to
improved lipid metabolism and increased serum antioxidant potential in rats.
ii.

Anti-inflammation
Reports have further shown that GS exerts anti-inflammatory effects, which again has

been attributed to the presence of a variety of phytochemicals, especially those present in the
bran. One such study compared the impact of hyaluronidase, which has been correlated with
chronic inflammation, in response to extracts obtained from wheat and rice bran and from brans
originating from six varieties of sorghum (Bralley, Greenspan, Hargrove, & Hartle, 2008). The
sorghum extracts were more effective in inhibiting hyaluronidase activity in vitro compared to its
counterparts. The responses were positively correlated to total phenolic content and ferric
reducing antioxidant power values. The researchers proposed that this inhibitory effect supports
the development of sorghum bran as an anti-inflammatory nutraceutical (Bralley, Greenspan,
Hargrove, & Hartle, 2008). Burdette et al. (2007; 2010) also tested the anti-inflammatory effect of
sorghum bran extracts in a 12-O-tetradecanoylphorbol acetate (TPA)-induced ear edema rat
model. The extract of black sorghum bran significantly decreased ear thickness and weights of
ear punches after TPA treatment in addition to inhibiting the secretion of the pro-inflammatory
cytokines interleukin 1-beta (IL-1β) and tumor necrosis factor alpha (TNF-α) (Burdette,
Hargrove, Hartle, & Greenspan, 2007) (Burdette, et al., 2010). Another study using the extract of
golden gelatinous sorghum bran showed that the expression level of cyclooxygenase 2 (COX-2)
and inducible nitric oxide synthase (iNOS) induced by 12-O-tetradecanoylphorbol-13-acetate
(TPA) were inhibited in a rat model (Shim, Kim, Jang, Ko, & Kim, 2013). Additionally, Hartle,
Greenspan, and Hargrove (2011) showed that the anti-inflammatory activity of the black sorghum
brans correlated with their phenolic content and antioxidant activity. Ritchie et al. (2011) also
reported that a black sorghum bran containing diet was able to remediate dextran sulfate sodium
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(DSS)-induced colonic inflammation and reduce the activation of the pro-inflammatory
transcription factor nuclear factor kappa B (NF-κB) in rats. It has been proposed that black
sorghum bran is able to protect against inflammation by altering the colon microbiota (Ritchie L.
E., Carroll, Weeks, Rooney, & Turner, 2012), species diversity, species richness (Ritchie, et al.,
2015) and the beneficial secondary metabolites produced by the microbiome (Ritchie, Sturino,
Azcarate-Peril, & Turner, 2013).
Other fractions of sorghum have also been reported to reduce inflammation at both the
cellular and the animal level. For example, aqueous and non-aqueous fraction of sorghum leaf
sheaths reduced ROS formation by inflammatory polymorphonuclear (PMN) cells and the
migration of these cells in response to the inflammatory chemoattractant leukotriene B4, with the
ethanol fraction inducing a similar effect (Benson, et al., 2013). Other research demonstrated that
a chloroform fraction of GS almost completely suppressed the lipopolysaccharide (LPS)-induced
production of nitric oxide (NO), TNF-α and interleukin 6 (IL-6) (Hwang, et al., 2013). As a major
constituent of GS, caffeoylglycolic acid methyl ester (CGME) was reported to exert antiinflammatory effects by inducing heme oxygenases (HO)-1 expression via the nuclear factor-E2related factor 2 (Nrf2)/heme oxygenase-1 pathway (Choo, et al., 2015). Caffeoylglycolic acid
methyl ester (CGME) along with benzoic and cinnamic acid derivatives from GS also inhibited
the production of NO and prostaglandin E2 (PGE2), IL-6 as well as the expression of iNOS, COX2 and IL-6 in LPS-stimulated RAW 264.7 cells (Nguyen, et al., 2015) (Choo, et al., 2015).

B. Grain sorghum lipid profile and health benefits
The GS whole kernel contains high levels of lipid (3.0-4.9%), comparable or higher than
many other cereal crops, such as corn (4.74%), wheat (1.71%), barley (1.16%) and rice (0.58%)
(Hwang, Kim, & Weller, 2005). Serna-Saldivar and Rooney (1994) showed that the germ of GS
contains the highest level of lipid (76.2%) followed by the endosperm (13.2%) and the pericarp
(10.6%).
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The lipid extract from the whole kernel, i.e., the lipid coating the surface of the kernel,
has been analyzed by Carr et al. (2005) using thin layer chromatography (TLC, Figure 1). The
lipid extract from whole kernel possesses a unique compositional profile, containing
hydrocarbons, steryl esters, wax esters, aldehydes, alcohols, triacylglycerol, diacylglycerol,
monoacylglycerol, free fatty acids and free sterols (Figure 2). This GS crude lipid (GS-CL) is
composed of a wax and an oil fraction at a 2:1 or 3:1 basis (Lee, et al., 2014) (Wang, Weller, &
Hwang, 2005). Hwang et al. (2002) showed that the wax fraction was composed of 46.3% fatty
aldehydes, 7.5% fatty acids, 41.0% fatty alcohols, 0.7% hydrocarbons, 1.4% wax esters and steryl
esters and 0.9% triacylglycerol. Alternatively triacylglycerols (~90%) were the most abundant
compounds in the oil fraction as shown by Lee et al. (2014), but other important lipids were also
present.
The health promoting potential of GS-CL has been mainly attributed to phytosterols and
policosanols, which are located in the oil and wax fraction, respectively (Althwab, Carr, Weller,
Dweikat, & Schlegel, 2015). In particular, evidence linking phytosterols to cholesterol lowering
and anti-cancer benefits is increasing (Carr, Ash, & Brown, 2010) (Awad & Fink, 2000).
Phytosterols present in the GS oil fraction exists as both free sterols and sterol esters (Singh,
Moreau, & Hicks, 2003), with the predominant sterols being β-sitosterol, campesterol and
stigmasterol (Leguizamón, Weller, Schlegel, & Carr, 2009). Phytosterol level ranges from 46 to
51 mg/100 g (Singh, Moreau, & Hicks, 2003) but varies depending on extraction method and the
physical state of the sorghum material (Leguizamón, Weller, Schlegel, & Carr, 2009).
Policosanols have also been reported to improve blood lipid profile (Gouni-Berthold &
Berthold, 2002) albeit other reports have disputed these claims (Lin, et al., 2004) (Dulin, Hatcher,
Sasser, & Barringer, 2006) (Murphy, Saint, & Howe, 2008). These compounds account for 3744% of the GS wax fraction (Hwang, Weller, Cuppett, & Hanna, 2004) with the major
policosanols consisting of octacosanol (28:0) and triacontanol (30:0) followed by hexacosanol
(26:0) and dotriacontanol (32:0) (Leguizamón, Weller, Schlegel, & Carr, 2009). Similar to the
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Figure 1 TLC analysis of white GS-CL (Carr, et al., 2005). TLC plate was developed in a solvent
system of hexane: diethyl ether: acetic acid (85:15:2, by volume).
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Figure 2 Illustration of lipid profile of white GS-CL (Carr, et al., 2005).
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whole kernel phytosterols, the policosanol composition and quantity can differ due to the
extraction method used, the physical form of GS (Leguizamón, Weller, Schlegel, & Carr, 2009)
and the type of GS as established in this study.
i.

Atherosclerosis
Carr et al. (2010) reviewed the positive impact of cholesterol lowering effect of

phytosterols when consumed for therapeutical purposes, especially in terms of low density
lipoprotein (LDL) cholesterol. Several researchers proposed that sorghum lipid extracts will
improve plasma and liver lipid profile due to its high phytosterol content. To test this hypothesis,
hamsters were fed a GS-CL supplemented (0.5, 1 and 5% w/w) fatty diet that was able to elevate
both plasma and liver low density lipoprotein (LDL) cholesterol (Carr, et al., 2005). Plasma nonhigh density lipoprotein (HDL) levels decreased significantly when the animals were fed the 1
and 5% supplement, resulting in a reduction of 40 and 65%, respectively, compared to the
animals fed the HF diet only. Plasma HDL cholesterol of the supplemented groups trended
upward with the GS-CL supplements although not significantly. In addition, cholesterol
absorption efficiencies of the hamsters consuming the 0.5, 1, and 5% GS-CL supplemented diets
were reduced by 62.5%, 59.7% and 56.6%, respectively, compared to 67.2% presented by the HF
group. The cholesterol lowering effect of GS-CL was thus attributed in part to the inhibition
cholesterol absorption. Using the animal pellets from the above described project, Martínez et al.
(2009) showed that the gut microbiota was altered and concluded that the cholesterol lowering
effect of GS-CL could also be partially attributed to this effect.
On the other hand, Hoi et al. (2009) showed that GS dry distiller grain with soluble
(DDGS) lipid fraction included into a HF diet also resulted in increased cholesterol excretion in a
dose-dependent manner (0, 0.5, 1 and 5% of GS-DDGS), which correlated to decreased liver
cholesterol concentration. Although plasma HDL levels were not affected by any of the doses,
non-HDL did decrease but only for the 5% supplemented fatty diet (by 69%).
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Lee et al. (2014) fractionated GS lipid obtained from whole kernel of white GS to the oil
and wax extracts and showed that the phytosterols and policosanols remain in the oil fraction and
in the wax fraction, respectively. Again using hamsters as the animal model, the oil supplemented
(5%, w/w) into a fatty diet resulted in significantly lower non-HDL plasma (25% reduction) and
liver esterified cholesterol (64% reduction). Alternatively, the wax supplement (5%, w/w) did not
affect either plasma or liver cholesterol, but did increase excreted neutral sterols and bile acids.
The researchers hypothesized that synergistic effects between oil and wax may be involved in the
anti-atherosclerosis effect of as the GS-CL (Carr, et al., 2005) exerted greater benefits when
compared to either the oil-wax fractionated results (Lee, et al., 2014). It must be noted however
that the former study used diets that contained lower fat levels than the latter study. Still, the lipid
fraction from the GS-DDGS (Hoi, et al., 2009) used a HF diet similar to that used in the original
GS-CL study (Carr, et al., 2005), but the cholesterol lowering effects were much less. As such,
synergism between the two fractions may play an important role in the protective properties of
GS-CL.
The GS-CL could also exert its cholesterol lowering effect through the regulation of
hepatic cholesterol metabolism, particularly effecting 3-hydroxy-3-methyl-glutaryl-coenzyme A
(HMG-CoA) reductase, sterol regulatory element-binding protein (SREBP)-2 and fatty acid
synthase. Kim, Kim & Park (2015) showed that all of these proteins were significantly
downregulated whereas AMPK phosphorylation was considerably upregulated in
hypercholesterolemia mice fed a GS supplement.
ii.

Gastrointestinal regulation
Cholesterol homeostasis improvements in response to GS-CL consumption has been

strongly associated with changes in gut microbiota based on a study of the gut microbiome of
hamsters consuming GS-CL (Martínez, et al., 2009). As previously described, the study indicated
that the regulating effects of GS-CL on hamster lipid profile, at least in part, act through the gut
microbiota. These conclusions were based on the data showing a strong correlation between HDL
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cholesterol levels and an increase in Bifidobacteria whereas a decrease in Coriobacteriaceae was
significantly associated with non-HDL cholesterol (Martínez, et al., 2009). The hypothesis that
dysregulated lipid profile could be attributed by the dysfunction of a single or several species of
gut microbiota was thus proposed. To test this hypothesis, systematic gut microbiome sequencing
and wide sampling from dyslipidemia population were needed. Therefore, in a latter study,
Martínez et al. (2013) used plant sterol esters (PSE) to mimic phytosterols present in GS-CL. The
results showed a prominent correlation between two species, Coriobacteriaceae and
Erysipelotrichaceae, and the host fecal and biliary cholesterol excretion, which fit a bacterial
inhibition model perfectly. The researchers further proposed that host cholesterol excretion
modulated the microbiota through the antibacterial action of cholesterol, whereas PSE did not
possess the inhibitory effect, which accounts for the different microbial composition between the
groups (Martínez, et al., 2013).

II.

Nutrient overload induces metabolic and energy switch
Exposure to excess nutrients and thereby energy is a modern phenomenon that has been

caused by changes in dietary patterns and lifestyles. Although temporary nutrient excess can be
accommodated and remediated by the inherent protective responses, chronic and persistent
nutrient overload irreversibly disturbs metabolic homeostasis, leading to the gradual development
of obesity (Zhang, et al., 2008). Indeed obesity has been linked to an array of metabolic disorders,
including insulin resistance and type II diabetes (Lionetti, et al., 2009), cardiovascular diseases
(Jia, Aroor, Martinez-Lemus, & Sowers, 2014) and even cancer (Taubes, 2012). The prevalence
of obesity and its associated medical disorders has increased dramatically in the U.S. and
throughout much of the world in the past decade (Jia, Aroor, Martinez-Lemus, & Sowers, 2014).

A. HF diets cause perturbations in energy metabolism
Of particular interest for our study, HF high cholesterol western diets induce prominent
changes in energy metabolism. In order to cope with HF high cholesterol and low glucose, cells
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switch to fatty acid β oxidation as the main energy source (Jiang , et al., 2013). Multiple
researchers have conducted studies using HF high cholesterol fed animal models to understand
the impacts of such a diet on human health. Zha et al. (2009) determined that a HF diet induces
significant elevations in plasma fatty acids in a hamster model, whereas Boulangé et al. (2013)
reported increased urine excretion of β oxidation intermediates in mice. Histopathological
assessment also revealed excessive organ lipid accumulation (Jiang , et al., 2013) (An, et al.,
2013). Examination of the urine showed higher circulating fatty acids and their metabolites
indicating the upregulation in fatty acid breakdown through β oxidation. These results also imply
fatty acid overflow through the mitochondria (Boulangé, et al., 2013). Excessive acetyl-CoA from
mitochondrial fatty acid oxidation may then be stored by accumulating around and entering key
organs, which has the potential of saturating the TCA cycle causing mitochondrial stress
(Boulangé, et al., 2013). Furthermore, Boulangé et al. (2013) showed that tricarboxylic acid
(TCA) cycle intermediates from succinyl-CoA to oxaloacetate (OAA) are significantly elevated
in the urine of HF fed mice. An et al. (2013) also determined that HF intervention increases the
levels of succinate and fumarate in rat liver. Chronic fatty acid overload in mitochondria leads to
mitochondria overwork and impairment and, in turn, damaged energy metabolism.
As the intake of a HF western diet progresses, low glucose supply becomes more evident.
Zha et al. (2009) and Guo et al. (2016) reported a reduction in plasma glucose level in a hamster
model 12 to 24 weeks into HF feeding. Moreover, An (2013) showed a reduction in liver glucose
and glycogen levels in a rat model. At the same time, circulating and liver alanine and lactate
trended upward due to HF diet and low glucose supply to the muscles (An, et al., 2013). These
results are most likely due to the lack of glucose as primary energy source, which is essential
nutrient for many tissues that include central nerve system and red blood cells. The depletion of
glucose thereby triggers the activation of several pathways employing non-carbohydrate substrate
to synthesis glucose (Boulangé, et al., 2013).
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Amino acid catabolism is significantly upregulated in animal models fed HF diets in an
effort to generate more glucose. For example, levels of many amino acids, including methionine,
phenylalanine, tyrosine, proline, tryptophan, glutamine, valine, lysine, glycine and histidine were
reduced in the plasma of HF high cholesterol fed hamsters (Zha, et al., 2009) and HF fed rats (An,
et al., 2013). Boulangé et al. (2013) also measured significant elevations of branched chain amino
acid (BCAA) catabolic intermediates in urine excreted by HF fed mice, including leucine,
isoleucine and valine intermediates. Coupled with higher levels of TCA intermediates from
succinyl-CoA to OAA, the researchers concluded that the upregulated BCAA catabolism feeds
into the TCA cycle as an anaplerosis source in order to produce glucose through gluconeogenesis
(Boulangé, et al., 2013). An et al. (2013) also supported this conclusion with an exception that the
HF diet group presented with significant reductions in urinary excretion of TCA intermediates
including citrate, α-ketoglutarate (α-KG), succinate and fumarate. Additionally, Kowalski et al.
(2015) performed an oral C13 glucose tolerance test on mice fed with a HF diet for 10 weeks.
Compared to control mice (no fat included in the diet), the muscles of the HF diet mice resulted
in a reduction of the C13 label for all the TCA cycle intermediates with the notable exception of
citrate. These results were attributed to a gradual carbon dilution that were contributed by the
alternative unlabeled carbon source entering the TCA cycle through multiple anaplerosis process,
such as glutaminolysis and other amino acid catabolism.
As HF diet consumption proceeded to 42 weeks, circulating glucose and hepatic glucose
and glycogen levels were restored via gluconeogenesis from amino acids and other noncarbohydrate substrates (Jiang , et al., 2013). Concurrently, urinary, hepatic and plasma alanine
and lactate levels were reduced as reported by Guo et al. (2016) and Jiang et al. (2013). However,
elevated glucose level remained in circulation without being taken up by cells due to a persistence
HF intake fulfilling the role as main energy source. Ultimately, a HF diet could initiate many
metabolic disorders, such as obesity, type II diabetes and atherosclerosis (Hotamisligil & Erbay,
2008) by initially eliciting stress responses.
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B. HF diets initiate intestinal stress via various mechanisms
Epidemiological studies have shown that a HF western style diet increases the risk of
inflammatory bowel diseases (Teixeira, et al., 2011) (Kim, Gu, Lee, Joh, & Kim, 2012). As
reported by Kim et al. (2010), a HF diet increased the susceptibility of mice to DSS-induced
inflammation and exacerbated the severity of DSS-induced colitis. Increased macrophage not
only infiltrated the sub-epithelial region of lamina propria but also at the base of crypts and in the
sub-mucosal layer (Erdelyi, et al., 2009) (Cheng, et al., 2016) (Kim, et al., 2010). Moreover, the
HF diet induced the expression of the pro-inflammatory cytokines (TNF-, IL-1, and IL-6) and
the activated pro-inflammatory enzymes and proteins such as NF-B, iNOS, myeloperoxidase
(MPO) and monocyte chemoattractant protein (MCP)-1 (Kim, Gu, Lee, Joh, & Kim, 2012)
(Bastie, et al., 2012).
Kim et al. (2012) showed that mice fed a HF diet exhibited higher endotoxin levels in
both plasma and fecal samples, indicating the progression of localized intestinal inflammation to
systemic inflammation. High circulating endotoxin levels also indicate increased intestinal
permeability. This research was supported by Murakami et al. (2016) and Kim et al. (2012) who
both showed reduced expression of tight junction proteins, markers for intestinal
hyperpermeability in the colon of mice fed a HF diet (Murakami, Tanabe, & Suzuki, 2016).
Intestinal permeability has been associated with gut microbiota dysregulation. For example, Kim
et al. (2012) showed that HF diet dysregulates gut microbiota by increasing the ratio between
Firmicutes and Bacteriodetes, and also induces the growth of Enterobacteriaceae in a mice
model. Shen et al. (2014) also reported that mice fed with HF diet have greater abundance of 3
types of sulfidogenic bacteria in colonic mucosa, resulting in the production of the proinflammatory compound, hydrogen sulfide (Carbonero, Benefiel, Alizadeh-Ghamsari, & Gaskins,
2012).
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In addition to local and systemic inflammation, Erdelyi et al. (2009) demonstrated that
the HF diet induces oxidative stress in colon, as genes involved in oxidative stress responses were
unregulated, including Nrf2, a redox sensitive transcription factor. Moreover, metabolic profiling
of colonic redox active compounds showed that HF feeding significantly reduces cysteine:
cystine ratio, providing further proof of colonic oxidative stress (Erdelyi, et al., 2009), which if
left unchecked can lead to chronic inflammation and associated diseases.

III.

Metabolomics research on bioactive food ingredients

A. Metabolomics
By definition, the metabolome is a “snapshot” of the entire complement of metabolites
produced at any given point in time by a biological system. It is therefore the goal of
metabolomics to describe, both qualitatively and quantitatively, the metabolome. Metabolomics
can thus monitor changes of the complete set of metabolites in and derived from an organism, the
end products of gene expression and/or in response to environmental changes (van der Werf &
Venema, 2001). Metabolomics is the most recent addition to the applied genomics technologies,
or the ‘omics’, that include genomics, transcriptomics and proteomics. Although the least well
defined of the ‘omics’ technology, metabolomics provides multiple attributes in terms of
understanding a complex system. Firstly, the number of metabolites (~2,500) is more than an
order of magnitude lower than the 30,000 to 40,000 genes in the human genome, making it a
simpler screening tool (Kell, 2006). Secondly, as metabolic pathways between species and
organisms are highly conserved (Nikolaev, Burgard, & Maranas, 2005) (Ravasz, Somera,
Mongru, Oltvai, & Barabási, 2002), metabolomics allows the use of biological models to reflect
biochemical changes in response to external stimuli (Weljie, Dowlatabadi, Miller, Vogel, & Jirik,
2007). And thirdly, as the final downstream outcome of the genome, transcriptome and proteome,
the metabolome reflects phenotype or function (Weljie, Dowlatabadi, Miller, Vogel, & Jirik,
2007). In other words, if the blueprint of any biological system is represented by the genome,
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then its function is expressed by its metabolome. Therefore, metabolomics is able to provide a
metabolic snapshot of an organism by bridging the genotype to phenotype gap.
The main challenges of metabolomic based research are the heterogeneity of the
molecules, low dynamic range of analytical techniques, limited through-put of the instruments
and the lack of validated extraction protocols. To date, it is impossible to analyze multiple classes
of metabolites with a single analytical method. Selection of appropriate metabolomic analytical
techniques is usually a compromise between high-throughput, selectivity and sensitivity
requirements. To achieve a comprehensive and accurate understanding of a metabolome, at least
two or more analytical techniques are needed. The most commonly employed analytical methods
include gas chromatography (GS), high performance liquid chromatography (HPLC), capillary
electrophoresis (CE), nuclear magnetic resonance (NMR), and mass spectrometry (MS) (Gries,
2008).
Two approaches are typically cited to conduct a metabolomics study, i.e., metabolic
profiling and metabolic fingerprinting, which simplifies the study of the metabolome. Metabolic
profiling refers to the analysis of a set of preselected metabolites with the goal of identifying and
quantitating each metabolite. However, this strategy limits the detection to molecules with
specific characteristics, such as similar chemistries (organic acids versus amino acids,) pathways
of origin (tricarboxylic acid vs eicosanoid pathway), biological relevance (specific metabolic
biomarkers) and / or physiological interactions (Dettmer & Hammock, 2004). As such metabolic
profiling provides precise and accurate changes to a wide array of key metabolites in response to
various genetic or environmental stimuli. When key metabolites can be analyzed simultaneously,
metabolic profiling can be equally or even more powerful as a global metabolomics, or metabolic
fingerprinting. The latter approach does not identify specific metabolites but rather compares
changes in patterns of metabolic responses to environmental stimulations or genetic perturbations
(Dettmer & Hammock, 2004). The entire data set or sub-set can then be analyzed by pattern
recognition and related multivariate statistical approaches to determine if the responses are
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significant between samples. Depending on the objective of a study, researchers are currently
applying one or both approaches (Lee, 2013).

B. Metabolomics as a tool to study the effects of dietary bioactive agents
Metabolomics has been employed to investigate the health benefits of bioactive food
ingredients although these studies remain limited. Nevertheless, Zhou et al. (2015) applied
metabolic profiling on the urine of a hyperlipidemia rat model by using ultra-performance liquid
chromatography (UPLC) coupled with electrospray ionization quadruple time-of-flight mass
spectrometry (ESI-QTOF-MS) to investigate the regulatory effect of mangiferin. The ensuing
data were then analyzed with principle component analysis (PCA) and orthogonal partial leastsquares discriminant analysis (OPLS-DA) to visualize the metabolic trajectory as a means to
discover potential biomarkers affected by a HF diet and mangiferin administration (Zhou, et al.,
2015). Li et al. (2015) employed proton nuclear magnetic resonance (1H NMR) coupled with
mass spectrometry to conduct metabolomic profiling on the urine of hyperlipidemia mice fed a
diet supplemented with curcumin. By combining the ‘omics’ with statistical analysis to study
nutraceutical intervention, the researchers were able to identify more natural substances that may
have medical values. Such applications provided the foundation for this research.
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2.

Objective and specific aims
The health promoting properties of most dietary components have been primarily studied

using isolated components despite emerging but limited research showing that whole food or
complex rich extracts impart greater health benefits than the sum of the individual components
(Junio, et al., 2011). Moreover, the metabolic mechanisms that recognize and respond to such
molecules and thereby promote a healthy state remain largely unknown. The objective of this
project was to determine the ability of GS-CL (rich in both health benefiting phytosterols and
policosanols) to protect energy pathways and the short chain fatty acid (SCFA) profile produced
by gut microbiome thus mitigate intestinal stress caused by a HF diet, which if left unchecked can
lead to hypoxia or inflammation, that in turn can progress into other chronic conditions.
Considering that the surface of GS contains a complex matrix of lipids, including phenols for
tannin containing sorghums, the central hypothesis for this project is that this richly diverse
extract is able to protect the following pathways, glycolysis, TCA, pentose phosphate pathway
(PPP), and amino acids (i.e., the precursors of many energy metabolites) against modulation
caused by a HF diet. Moreover, the GS-CL is expected to prevent the HF diet from interfere the
production of SCFA produced by the gut microbiome. This hypothesis was tested by completing
the following specific aims.
Specific Aim 1: To determine the ability of different dosages of red GS-CL (1,3 and 5%)
to prevent intestinal stress caused by a HF diet by monitoring key energy pathways
(carbohydrate, amino acid and nucleotide metabolism) by using a hamster model and metabolic
profiling approaches. The working hypothesis for this aim is that the red GS-CL will provide a
protective response against HF induced energy modulation in intestine but the degree will be
dependent on GS-CL dosages.
Specific Aim 2: To determine the ability of different dosages of red GS-CL (1,3 and 5%)
to prevent the impact of HF diet on the production and profile of SCFA in large intestine. The
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working hypothesis for this aim is that the red GS-CL will provide a protective response against
the inhibitory effect of HF diet on SCFA profile produced by the gut microbiome.
Specific Aim 3: To characterize red GS-CL in terms of its chemical compositions. The
accessed need for this aim is that such information was required to ultimately determine the
components responsible for protecting against intestinal stress.
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3.

Material and methods

I.

Specific Aim 1 and 2: Metabolic actions of fatty diet without and with
different doses (1, 3, 5%) red grain sorghum crude lipid on key energy
pathways and SCFA profile

A. Grain sorghum crude lipid extraction
The GS-CL was prepared with food grade dark red high tannin GS whole kernel (a
germplasm line from the Texas AES-USDA sorghum conversion program) provided by Dr.
Ismail Dweikat (University of Nebraska-Lincoln) and Nu Life Market, Kansas, grown and
harvested in 2014. The GS-CL was extracted from the surface of red GS by refluxing, previously
described by Leguizamón et al. (2009). Briefly, whole kernel red GS (1 kg) was refluxed with
hexane (1 L) for 30 min at a temperature slightly below 60 °C in a three-neck round bottom flask
connected to a condenser. The mixture was cooled to room temperature and then passed through
two layers of coffee filter and a Whatman No. 2 filter under vacuum. The solvent was evaporated
from the GS extract using a rotavapor. The residue GS-CL was collected and stored at -18°C until
use.

B. Diet and animal care
Five different diets were prepared based on the AIN-93M purified diet, which consisted
of a negative control (low fat), an high fat (HF) positive diet and three HF diets supplemented
with either 1.0, 3.0, and 5.0% (w/w) GS-CL (Table 1). For the HF diets, coconut oil, cholesterol
and GS-CL supplements were added at the expense of cornstarch.
Fifty five male Syrian hamsters (Charles River, Wilmington, MA), age 9 weeks with
body weight ranging from 110 to 120 g, were used for this study. The hamsters were randomly
assigned to the five experimental diets (n=11) to ensure a similar average weight among the
groups. Each hamster was housed individually in polycarbonate cage with wood chip bedding in
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a controlled environment of 25 °C with a 12 h light-dark cycle, and had free access to water and
food. The animals were maintained on their assigned diet for 4 weeks, and their food intake was
recorded on a weekly basis. The bedding was also changed weekly, whereas the body weight of
each hamster was measured at baseline and at the end of the study. Food was removed 14 h
before CO2 asphyxiation to achieve overnight fasting. The large intestine was collected,
immediately frozen with dry ice and stored at -80 °C until analyzed. All experimental procedures
were approved by the Institutional Animal Care and Use Committee at the University of
Nebraska.

C. Extraction of targeted metabolites
Metabolite extraction was initiated by grinding the frozen large intestinal tissue in dry ice
until a fine powder was produced. Approximately 120 mg of the ground tissue was weighed in a 1
mL glass homogenizer followed by the addition of 1 mL ice-cold nanopure water. The tissue was
then homogenized while maintained in flaked ice until no large tissue pieces were visible. The
homogenate was then centrifuged with a Beckman GS-6R centrifuge at 4°C for 30 min, which
completed pelleted the solid material. The supernatant was collected and passed through a EMD
Millipore Amicon centrifugal filter unit 10 KDa to achieve a clear, protein-free metabolite
extract. The extract was concentrated with a Labconco CentriVap concentrator to a total volume
of approximately 100 µL (Figure 3).

D. Analysis of tissue extracts
The eight glycolysis intermediates and two pentose phosphate pathway intermediates
were analyzed using a LC-ESI-MRM-MS. Samples were evaporated to dryness using a Speedvac concentrator (Thermo Savant Instruments, USA) at 4 °C. The pellets were re-dissolved in 50
µL of nanopure water and vialed prior to injection on the LC system. The HPLC (Agilent 1200
series, Santa Clara, CA) separation was achieved using an XBridge Amide column (2.1 × 100
mm, 3.5 µm) ( Waters Millipore, Milford, MA). The mobile phase consisted of 20 mM
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Table 1 Composition of five hamster diets.

Food Component*

Control

HF1

HF + 1%
GS-CL2

HF + 3%
GS-CL2

HF + 5%
GS-CL2

Cornstarch

455.7

353.7

343.7

323.7

303.7

Dextrinized cornstarch

155.0

155.0

155.0

155.0

155.0

Casein

140.0

140.0

140.0

140.0

140.0

Sucrose

100.0

100.0

100.0

100.0

100.0

Coconut oil

---

100.0

100.0

100.0

100.0

Soybean oil

50.0

50.0

50.0

50.0

Insoluble fiber
(cellulose)

40.0

40.0

40.0

40.0

40.0

Soluble fiber
(guar gum)

10.0

10.0

10.0

10.0

10.0

GS-CL

---

---

10.0

30.0

50.0

Cholesterol

---

2

2

2

2

AIN-93 mineral mix

35.0

35.0

35.0

35.0

35.0

AIN-93 vitamin mix

10.0

10.0

10.0

10.0

10.0

L-Cysteine

1.8

1.8

1.8

1.8

1.8

Choline bitartrate

2.5

2.5

2.5

2.5

2.5

50.0

* Dyets, Inc. Bethlehem, PA;
1
HF diet contained extra coconut oil and cholesterol at concentrations of 10% and 0.2%, respectively, at the expense of cornstarch;
2
GS-CL were added at 1.0, 3.0 and 5.0% at the expense of cornstarch.
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Figure 3 The extraction of tissue metabolites.
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ammonium hydroxide and 20 mM ammonium acetate in nanopure water (A) and LC-Grade
Acetonitrile (B). The gradient began at 5% A and 95% B for 3 min, then to 95% B over 10
column volumes, 95% B over 5 column volumes and finally 5% A over 10 column volumes; all
steps at a flow rate of 0.5 mL/min. The eluent of the column was fed into the electrospray ion
(ESI) ion source operating in negative ionization mode at a voltage of -4500 V, at a temperature
of 500 °C and with source gasses at 60 L/min (GS1 and GS2). Multiple reaction monitoring
(MRM) was employed for metabolite detection and quantification on a Sciex 4000QTrap
(Framingham, MA). A single precursor and single fragment m/z values were paired for the
detection of each metabolite. External standards at 10 ug/mL were used for calibration (SigmaAldrich, St.Louis, MO). All data was normalized according to tissue weight, and each metabolite
was expressed as mean +/- standard error of the mean (µg/g) of eleven biological replica.
Amino acids were analyzed using EZ: faastTM amino acid analysis kit (Phenomenex Ltd.
Germany) as per manufacturer’s instructions. This analysis consisted of a solid phase extraction
step followed by a derivatization and a liquid/liquid extraction, and the derivatized samples were
quickly analyzed by gas chromatography with FID detection. More specifically, the solid phase
extraction was performed via a sorbent packed tip that binds amino acids while allowing
interfering compounds to pass through the column. The amino acids bound to the sorbent were
then released with sodium hydroxide, 3-picoline and N-propanol. The sample mixture was
allowed to incubate at room temperature during derivatization, which was accomplished with the
above mentioned reagent. After a clear separation occurred between the organic and aqueous
phases, the upper organic phase containing the derivatized amino acids was collected and
analyzed on an Agilent 7820A GC instrument with a flame ionization detector (FID) detector.
The amino acids present in the extracts were resolved, identified and quantified with a 10m ×
0.25mm ZebronTM EZ-AAA amino acid GC column under the following conditions: initial oven
temperature 110 °C, rising to 320 °C at 32 °C/min with the injector temperature set at 250 °C.
The carrier gas was helium adjusted to a split ratio of 15:1. Each amino acid was quantified
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against an internal standard (Norvaline). All data was normalized according to tissue weight and
each amino acid was expressed as mean +/- standard error of the mean (µg/g) of eleven biological
replica.
The remaining metabolites listed (Table 2) were analyzed with Beckman P/ACE MDQ
capillary electrophoresis system (Beckman Coulter, USA) interfaced to a 67 cm long Agilent bare
fused silica capillary (i.d. 50 µm) and a 200 nm UV filter. A 250mM sodium phosphate buffer
(pH 6.0) containing 0.1 mM hexadecyltrimethylammonium bromide (CTAB) and 5% methanol
served as background electrolytes (BGE) and the samples were injected onto the capillary using a
pressure of o.5 psi for 5 sec, and the metabolites were separated at 25 °C and 10 KV. For all the
CE assays, the capillary was preconditioned regeneration solution (0.1 N NaOH, Beckman
Coulter, USA) for 2 min and running buffer for 2 min. After each run, the capillary was cleaned
by rinsing with 1 M HCl for 2 min, capillary regeneration solution for 5 min and nanopure water
for 2 min. All solutions and samples were filtered by a 0.45 µm filter unit before injected to the
capillary. Standard curves for each metabolite were constructed with a cocktail containing
external standards. The sample analyte peaks were identified by both retention time and standard
spikes. System control, data acquisition, and data analysis were performed with a Beckman 32
Karat workstation. All data was normalized according to tissue weight and each metabolite was
expressed as mean +/- standard error of the mean (µmol/g) of eleven biological replica.

II.

Specific Aim 3: Characterization of grain sorghum (sorghum bicolor)
crude lipid
The simple lipid profile was acquired using thin layer chromatography (TLC), as

described by White et al. (1998). A cocktail of standards containing monoacylglycerols, 1,2diacylglycerols, 1,3-diacylglycerols, triacylglycerols, fatty acid methyl esters, D-α-tocopherol
acetate, three polyoxyethlenesorbitan monooleate and octacosanol was prepared. Approximately
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Table 2 Metabolites of targeted metabolomic profiling.
Metabolites

Analytical method

Glucose-1-phosphate

MS

Glucose-6-phosphate

MS

Fructose-6-phosphate

MS

Fructose-1,6-phosphate

MS

Dihydroxyacetone phosphate

MS

Glyceraldehyde-3-phosphate

MS

Glycerol-3-phosphate

MS

Glycerate-3-phosphate

MS

Phosphenolpyruvate

CE

Pyruvate

CE

Ribose-5-phosphate

MS

Ribose

MS

Acetyl-CoA

CE

Citrate

CE

α-ketoglutarate

CE

Succinate

CE

Malate3

CE

Fumarate

CE

NAD+

CE

NADH

CE

NADP+

CE

NADPH

CE

GSH

CE

GSSG4

CE

Oxalate2

CE

Formate

CE

Malonate1

CE

Acetate

CE

Propionate

CE

Butyrate1

CE

Lactate1

CE

Glycolysis

Pentose phosphate pathway

TCA cycle

Coenzymes

Organic acids
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Amino acids

Alanine

GC

Sarcrosine

GC

Glycine

GC

α-aminobutyric

GC

Valine

GC

Leucine

GC

Isoleucine

GC

Threonine

GC

Serine

GC

Proline

GC

Asparagine

GC

Aspartic acid

GC

Methionine

GC

Hydroxyproline

GC

Glutamic acid

GC

Phenylalanine

GC

Glutamine

GC

Ornithine

GC

Lysine

GC

Histidine

GC

Tyrosine

GC

Tryptophan

GC

Cysteine

GC

ATP

CE

ADP

CE

AMP

CE

GTP

CE

GDP

CE

GMP

CE

Nucleotides

All amino acid standards come from EZ: faastTM kit, the rest of standards were purchased from Sigma-Aldrich, except for the
following:
1
Standard purchased from Alfa Aesar;
2
Standard purchased from Fisher chemical;
3
Standard purchased from MP Biomedicals, LLC;
4
Standard purchased from Fluka.
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25 mg of the extracted GS-CL was suspended in 1 mL of chloroform to a final concentration of
20 mg/mL. The GS-CL was completely dissolved by heating to 60°C. The sample and standard
was spotted on a 10 × 20 cm silica gel 60 plate using 10 µL aliquots. The plate was then placed in
a resolving chamber containing hexane, diethyl ether and acetic acid (85:15:2, by volume) until
the solvent had eluted near the top of the plate. The plate was removed and submerged briefly in
10% cupric sulfate, 8% phosphoric acid solution and air-dried in a chemical fume hood. Bands
were visualized by charring the dried plate in an oven adjusted to165 °C for 10 min.
The GS-CL fatty acid profile was analyzed with a Agilent 7820A gas chromatograph
(GC) system interfaced to a FID, and the resolution method used was based on the procedure
previously described by Metcalfe et al. (1966). Briefly, a sample of GS-CL (0.05 g) was
derivatized to volatile fatty acid methyl esters (FAMEs) by mixing with 2 mL of 14% boron
trifluoride in methanol and heating at 100 °C for 5 min. After cooling to room temperature, the
FAME were extracted with 1:2 hexane and water (v/v) by centrifugation until a well-defined
pellet had formed. The FAMEs-containing hexane layer was analyzed using a GC DB-Wax
column (30 m × 0.25 mm, J&W Scientific) under the following conditions: initial oven
temperature was 185 °C for 12 min, increased to 210 °C at 10 °C /min, held for 1 min using a
FID temperature of 250 °C. Helium served as the carrier, which was set at a split ratio of 10:1.
Fatty acid levels were reported as relative percent of 100% crude lipid.
Quantification of phytosterols and policosanols present in the GS-CL was achieved by
GC (Agilent 7820A GC system) interfaced to a FID. Based on the procedure described by
Leguizamón et al. (2009), a GS-CL sample (0.02 g) was mixed with the internal standards, 0.1
mg 5α-cholestane and 0.1 mg policosanol heptacosanol (C27). The mixture was saponified with 1
M methanolic potassium hydroxide at 50 °C for 1 h with occasional agitation. Non-saponifiable
lipids were separated by adding 1 mL of deionized water and 3 mL of hexane to the mixture. The
hexane phase was separated by centrifuging at 3000×g for 5 min and evaporated under nitrogen at
50 °C. The dried lipids were derivatized by reacting with 100 µL pyridine for 30 min followed
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by the addition of 50 µL Sylon BTZ (Supelco, Bellefonte, PA, USA) at room temperature. Each
sample was analyzed with a 0.32 mm × 30 m DB-5 capillary column (J&W Scientific, Folsom,
CA, USA) under the following conditions: initial oven temperature was 100 °C, rising to 300 °C
at 5 °C/min with the injector and FID temperature set at 270 °C and 300 °C, respectively. Helium
served as the carrier, which was adjusted to a split ratio of 50:1. External phytosterols were used
to identify and quantitate the individual phytosterols that included stigmasterol, sito-sterol and
campesterol. Each type of policosanol and sterol were expressed as the mean +/- standard
deviation (µg/g of lipid extract) of triplicate analyses.
Tocopherols present in the GS-CL extract were determined following a colorimetric
method described by Wong, Timms and Goh (1988) with minor modification. A sample (200 mg)
was weighed into a 10 mL volumetric flask and 5 mL hexane: isopropanol (3:2, v/v) was then
added. The GS-CL was allowed to dissolve in this solvent by occasionally agitating the sample at
room temperature followed by adding 3 mL of 0.07% 2,2’-bipyridine in 95% ethanol and 0.5 mL
0.2% ferric chloride in 95% ethanol sequentially. The sample was bought to a final volume of 10
mL with 95% ethanol, and absorption was measured with a Beckman Coulter DU800
spectrophotometer at 520 nm. An external calibration curves was constructed using the same
method but employing the standard, α-tocopherol. Tocopherol levels in the sample were
calculated as the mean +/- standard deviation mg equivalents of α-tocopherol per g of crude lipid
of triplicate analyses.
Carotenoid levels were determined following a colorimetric method described by
Lichtenthaler and Buschmann (2001). A sample of GS-CL(200 mg) was weighed into a screw
cap tube followed by the addition of 1.6 mL methanol: water (94:6, v/v). The mixture was
sonicated for 30 min in 45-50 °C water bath, and then centrifuged for approximately 5 min to
collect a clear supernatant. After previous steps were repeated two additional times 1.2 mL of
methanol: water (94:6, v/v) were added to the sample to a final volume 6 mL. The solution was
then centrifuged until clear supernatant was obtained, and the absorbance was measured with a
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Beckman Coulter DU800 spectrophotometer at 470, 853 and 666 nm. The concentration of
carotenoid was calculated as µg per g GS-CL by the following equations:
𝐶ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐴 (𝜇𝑔⁄𝑚𝑙 ) = 15.65𝐴666 − 7.34𝐴653
𝐶ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐵 (𝜇𝑔⁄𝑚𝑙 ) = 27.05𝐴653 − 11.21𝐴666
𝐶𝑎𝑟𝑜𝑡𝑒𝑛𝑜𝑖𝑑𝑠 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝜇𝑔⁄𝑚𝑙 ) = (1000𝐴470 − 2.86)×(𝑐ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐴 − 129.2)×
𝑐ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐵⁄245.
This test was completed in triplicate and the carotenoid levels were expressed as the mean +/standard deviation (µg/g of lipid extract).
Lastly, tannin levels were determined by following a liquid-liquid extraction method
described by Fuentes et al. (2012). A sample (2.5 g) of GS-CL was dissolved in 5 mL of hexane
followed by the addition of 3 mL methanol:water (60:40, v/v). The mixture was centrifuged to
achieve a clear phase separation. The methanol phase was collected, and the liquid/liquid
extraction was repeated an additional time. The methanol phases from the two extractions were
combined for tannin detection following a colorimetric method described by Bhat, Sridhar, and
Tomita-Yokotani (2007). The methanol extract (1 mL) was combined with 5 mL of 4% vanillin
in methanol and 8% HCL in methanol (1:1). After 20 min of incubation at room temperature, the
absorbance was measured at 500 nm. Tannin levels were determined by constructing a calibration
curve using catechin as an external standard. The tannin content was expressed as the mean +/standard deviation of mg equivalents of catechin per g GS-CL of triplicate analysis.

III.

Statistical Analysis
Univariate comparisons between control and HF groups were performed in R using non-

parametric Kruskal-Wallis test. Pairwise comparisons among the five treatment groups were
performed in GraphPad Prism version 7 (GraphPad Software, La Jolla CA, USA) using one-way
ANOVA followed by Tukey’s multiple comparison after confirming normal distribution in R. To
compare metabolic changes among the groups, multivariate analysis was conducted, including
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partial least squares-Discrimination analysis (PLS-DA) and orthogonal-PLS-DAs which were
performed with MetaboAnalyst 3.0 (www.metaboanalyst.ca) and SIMCA-P+ 12.0 software
(Umetrics; Sweden), respectively.
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4.

Results and discussion
The health promoting properties of GS-CL reported to date has mainly focused on

cholesterol management (Carr, et al., 2005) (Lee, et al., 2014) (Hoi, et al., 2009) with fewer
reports on its role in modulating the intestinal microbiota (Martínez, et al., 2009) (Lee, 2013).
Despite these established benefits, a critical gap in information remains on the impact of GS-CL
on cells or tissues at the “omics” level, with an exception of a study performed by Lee (2013). In
the latter research, metabolomic profiling was performed on both the liver and large intestine
collected from hamsters fed HF diets supplemented with either 5% white GS oil or wax. The
supplemented diets compensated for the changes caused by a HF diet to a large degree in large
intestine, but the liver metabolome was affected only minimally (Lee, 2013). In the current study,
metabolites of key energy pathways were profiled more extensively to achieve a comprehensive
understanding of the mode of action behind this compensation in large intestine, and to determine
if different lines of sorghum provided different benefits. Furthermore, the SCFA produced by the
gut microbiome were also analyzed to determine whether the red GS-CL were able to mitigate the
effects of HF on the microbiome. Lastly, the GS-CL was thoroughly characterized to provide
information of the possible component(s) responsible for these effects.

I.

Animal body weight and food intake
Baseline body weight of the hamsters were not significantly different among groups

(117.13 ± 0.08 g). After the four week feeding study, each group gained weight (129.2 ± 2.7 g)
with an average gain of 13.4 ± 2.1 g, which was not statistically different among the groups. In
addition, food intake throughout the study remained constant for all groups (9.8 ± 0.5 g/day),
showing that the supplemented diets were palatable.
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II.

Specific aim 1: Metabolic actions of HF diet without and with different
doses (1, 3 and 5%) of red GS-CL on key energy pathways

A. The effect of a HF diet on cellular central carbon metabolism
i.

Effect of HF diet on cellular energy production and redox balance
Cellular energy status is reflected by the index “energy charge”, first defined by Atkinson

and Walton (1967), which is shown below.
𝐸𝑛𝑒𝑟𝑔𝑦 𝑐ℎ𝑎𝑟𝑔𝑒 =

[𝐴𝑇𝑃] + 12[𝐴𝐷𝑃]
[𝐴𝑇𝑃] + [𝐴𝐷𝑃] + [𝐴𝑀𝑃]

When applied to the nucleotide data obtained from the intestinal analysis of both the control and
HF groups, a significantly lower energy level (0.062 ± 0.004) was detected in the HF group than
that of the control (0.297 ± 0.102) (Figure 4). These results thus confirm that a HF diet affects the
ability of intestinal cells to generate energy, creating a hypoxic stress relative to a low fat diet.
The HF diet consumed by the model system may have impaired their ability to generate
energy by multiple mechanisms. First, the HF diet contained 10% more fat and less starch than
that of the control diet (Table 1). Excessive fatty acids may have accumulated quickly in
mitochondria for β oxidation, thereby over-stressing the organelle. This stress may have resulted
in possible damages to the electron transport chain (ETC) (Boulangé, et al., 2013), and/or
impairment to its ability to recycle NADH to NAD+. As is shown in Figure 5, the HF group
presented with significantly lower NAD+ (4.05 ± 0.41nmol/g) when compared to control group
(6.19 ± 0.65 nmol/g). The NAD/NADH ratio corresponding to the HF group (0.343 ± 0.029) was
also much lower than that of the control group (0.488 ± 0.080). Similar to these results, several
studies have shown that under excessive substrate availability, whether the substrate was glucose,
lipid or amino acids, NAD+ decreased in skeletal muscle, liver and heart (Gumaa, McLean, &
Greenbaum, 1971) (McGarry & Dobbins, 1999) (Vettor, et al., 1997). As the carrier of electrons
generated from glycolysis and the TCA, the lower NAD+ and NAD/NADH ratio obtained from
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Figure 4 Energy charge for control and HF groups. Values are shown as the means ± SEM, n=11. Statistical
differences were evaluated using non-parametric Kruskal-Wallis test.

34

Figure 5 NAD+ and NAD/NADH ratio of control and HF groups. Values are shown as the means ± SEM, n=11.
Statistical differences were evaluated using non-parametric Kruskal-Wallis test.
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our studies denote a reduction in the ability of the intestinal cells to generate energy by disrupting
cellular redox balance and causing oxidative stress (Rosca, et al., 2012).
This hypothesis was tested by monitoring glutathione in both its reduced (GSH) and
oxidized forms (GSSG) as GSH is considered one of the most important free radical scavengers.
The ratio of GSH/GSSG has thus been employed as a marker of cellular redox balance and
oxidative stress (Zitka, et al., 2012). For the HF group, the GSH/GSSG ratio and GSH level were
0.336 ± 0.026 and 0.015 ± 0.000 µMol/g respectively, trending lower than the 0.523 ± 0.108 and
0.018 ± 0.002 µMol/g of the control group (Figure 6). Similarly, Ajiboye et al. (2016) also
reported a decrease in GSH and GSH/GSSG ratio in the livers of HF fed rats.
ii. Effect of HF diet on central carbon metabolism
Glucose is the primary energy source for many organs, including the large intestine.
Therefore, when fat is present in the diet at high levels, the cells are forced to use fatty acids as an
energy income to accommodate the excessive fat and, at the same time, manage and/or
compensate for the less-than-sufficient glucose (Boulangé, et al., 2013). Metabolite changes were
thus investigated in large intestine by applying an OPLS-DA approach to compare animals fed a
low fat control to those on a HF diet. As shown by OPLS-DA score plot (Figure 7A), the control
clearly separated from the HF group. Based on the coefficient plot (Figure 7B), the levels of
multiple metabolites in the HF group were elevated, including formate, fumarate, succinate,
malate, PEP, acetate, AMP, GSSG. In contrast, decreased levels of oxalate, propionate, ATP,
ADP, acetyl-CoA and most of the amino acids were also evident.
Acetyl-CoA is considered a metabolic intersection due to its connection with many
metabolic pathways, such as glycolysis and the TCA cycle, fatty acid and amino acid metabolism,
protein acetylation and DNA methylation (Carrer, et al., 2017). The flux of this intermediate in
and out of mitochondria thus represents the metabolic state of a cell as “fed” or “starved” (Shi &
Tu, 2015). Under conditions of sufficient glucose or a “fed” state, acetyl-CoA from glycolysis
fluxes out of the mitochondria for fatty acid synthesis and storage (Shi & Tu, 2015). However,
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Figure 6 GSH/GSSG ratio and total glutathione in control and HF groups. Values are shown as the means ± SEM,
n=11. Statistical differences were evaluated using non-parametric Kruskal-Wallis test.

Figure 7 OPSD-DA score plot (upper) and coefficients (lower) for control and HF groups. Score plot R2X=0.46, R2Y=0.95, Q2=0.886. Positive
bars (± SEM) of coefficient plot donate metabolites significantly increased when diet switch from control to HF.
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under high fat and low carbohydrate conditions, a cell undergoes a pseudo starvation state by
employing fatty acid β oxidation as a source for acetyl-CoA production. Most of the acetyl-CoA
is maintained inside the mitochondria by inhibiting the activity of ATP citrate lyase (ACLY)
(Carrer, et al., 2017), which catalyzes the conversion from acetyl-CoA to citrate. In the current
experiment, the cellular net acetyl-CoA produced by the HF group was lower than that of the
control group (p=0.112). Similarly, Carrer et al. (2017) reported a reduction of acetyl-CoA in a
HF diet mice model. These results indicate that, as a source of acetyl-CoA, fatty acid is not as
readily used and efficient as glucose, and the total generation of acetyl-CoA in a cell is slower
when fatty acid is the major energy source (Fillmore, Mori, & Lopaschuk, 2014).
Due to the low acetyl-CoA and energy generation under HF diet, the cell is most likely
restoring homeostasis by gluconeogenesis. Positioned at the very center of carbon metabolism,
the TCA cycle functions as a metabolite hub, receiving carbon flow from different substrates and
redirecting them to gluconeogenesis (Satapati, et al., 2012). As is shown in Figure 8, pyruvate
reduction was not significant in HF group, but aspartate, which is convertible with OAA,
decreased significantly (p=091). Combining the latter results with the significant increase in
phosphoenolpyruvate (PEP) (p=0.002), and trending, but insignificant increase in glycerate-3phosphate (3PG), glyceraldehyde-3-phosphate (GA3P) and glucose-1-phosphate (G1P), these
changes indicates that HF group is undergoing mitochondria TCA anaplerosis from pyruvate to
OAA followed by a cataplerosis from OAA to PEP (Sunny, Parks, Browning, & Burgess, 2011).
Pyruvate is not the only source of TCA anaplerosis as elevated amino acid anaplerosis
has been reported on multiple studies conducted with HF diet animal models (An, et al., 2013)
(Boulangé, et al., 2013) (Zha, et al., 2009). As is shown in Figure 9, amino acid catabolism was
also higher in the HF group in a significantly large and wide scale. Ketogenic lysine and branch
chain amino acid (BCAA) including leucine, isoleucine and valine significantly decreased
combined with a decreasing, but insignificant, trend in glycogenic glutamate, proline, ornithine,

Figure 8 Central metabolism under HF influence. Values are shown in boxplot (upper whisker-upper quartile-median-lower quartile-lower
whisker). Statistical differences were evaluated using non-parametric Kruskal-Wallis test.
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Figure 9 Amino acid metabolism and gluconeogenesis under HF influence. Values are shown as the means ± SEM, n=11. Statistical analysis
ANOVA and Tukey’s multiple comparison was conducted (***p≤0.001, **p≤0.01, *p≤0.05).
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threonine, glycine, serine and alanine. Other amino acids, including glutamine and aspartate also
declined, albeit not significantly.
These results indicate that carbon flowed from amino acids and entered into the TCA
cycle at different points, such as α-ketoglutarate, succinyl-CoA, fumarate, OAA and acetyl-CoA,
thereby significant increasing TCA intermediates, especially succinate and fumarate (Figure 9).
Satapati et al. (2012), An et al. (2013), and Boulangé et al. (2013) also reported elevated TCA
metabolites in the presence of a HF diet. Satapati et al. (2012) proposed that the cells are in
relatively oxidized redox state accompanied by a slower TCA cycle rate thereby causing other
metabolic complications. For example, elevated fumarate and succinate have been shown to
inhibit HIF-1α prolyl hydroxylase, resulting in hypoxia-inducible factor 1-alpha (HIF-1α) protein
accumulation, which, in turn, causes a pseudo hypoxic cellular response (Koivunen, et al., 2007)
(Selak, et al., 2005).

B. The impact of red grain sorghum crude lipid on central carbon metabolism in the
presence of a HF diet
i.

Effect of GS-CL supplements on HF stressors: energy and redox balance
Lee (2013) showed that lipids extracted from the whole kernel GS were able to modulate

central carbon metabolism in both the liver and the large intestine of golden Syrian hamsters, but
this study used fractioned oil and wax. In the current study, we show for the first time the impact
that whole kernel GS-CL, that contains both the wax and oil fraction, has on cellular energy status
in the presences of a HF diet. As is shown in Figure 10, energy charges obtained from three GSCL supplemented groups all increased significantly, with the highest positive change occurring in
the 3% GS-CL supplemented animals. This benefit, however, is not completely does-dependent,
as the 5% group did not recover as well as 3% group. Improved energy charge could be attributed
by two possible reasons, motivated mitochondria TCA cycle or activated AMP activated protein
kinase (AMPK) complex (Wang, et al., 2015) (Kang, et al., 2015). Although experiment have yet
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to be conducted to determine AMPK activity, a motivated TCA cycle was indeed observed in GS
supplemented groups, which will be discussed in next session.
In terms of redox balance, the GS-CL was not able to reverse the low level of NAD+ and
GSH caused by HF diet, GS-CL supplemented groups were not significantly different for either
of these metabolites compared to the HF group (Figure 11A and Figure 12A). The metabolite,
NADH remains nearly constant among all five groups (Figure 11B), yet there might be a slight
upward trend in the NAD/NADH ratio to a ratio closer to the control occurred among the GS-CL
supplemented groups in a dose dependent manner (Figure 11C).
The improvement in the GSH/GSSG ratio (Figure 12C) produced by 1% supplemented
diet is certainly evident. Interestingly, it was achieved by breaking down GSSG without a
concomitant increase in GSH (Figure 12B). (Reduction of 1mole GSSG to 2 moles GSH is
catalyzed by glutathione reductase at the expense of NADPH, which was oxidized to NADP+
(Lushckak, 2012)). Incidentally, NADP+ in 1% group was higher compared to other groups
(Figure 13B), which could be the reason for the significant reduction of GSSG. The whereabouts
of the regenerated GSH from GSSG after reduction is illusive. However, GSH may have been
used to elevate the activity of glutathione S-transferase (GST) enzymes and increased GSH
detoxification capacity (Lushckak, 2012), but more studies are needed to test this hypothesis.
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Figure 10 Effect of GS-CL on cellular energy charge. Values are shown as the means ± SEM, n=11. Statistical analysis
ANOVA and Tukey’s multiple comparison was conducted (***p≤0.001).

Figure 11 Effect of GS-CL on NAD+, NADH and their ratio. Values are shown as the means ± SEM, n=11. Statistical analysis ANOVA and Tukey’s
multiple comparison was conducted (**p≤0.01).
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Figure 12 Effect of GS-CL on GSH, GSSG and their ratio. Values are shown as the means ± SEM, n=11. Statistical analysis ANOVA and Tukey’s multiple
comparison was conducted (*p≤0.05, ***p≤0.001).

45

Figure 13 Effect of GS-CL on NADP+, NADPH and their ratio. Values are shown as the means ± SEM, n=11. Statistical analysis ANOVA and Tukey’s
multiple comparison was conducted (*p≤0.05, ***p≤0.001).
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Other changes to metabolite redox couples may show additional insights into the cellular
redox state (Figure 14). The malate-aspartate shuttle (MAS) and the glycerol-3-phosphate (G3P)
shuttle are the primary and secondary pathways that are able to recycle glycolysis-generated
cytosolic NADH back to NAD+. The shuttles are required because the mitochondrial inner
membrane is impermeable to NADH (Easlon, Tsang, Skinner, Wang, & Lin, 2008). To
circumvent this obstacle, malate and G3P transports the reducing equivalents into mitochondria
(Easlon, Tsang, Skinner, Wang, & Lin, 2008), whereas the lactate/pyruvate couple recycles
glycolytic NADH to NAD+ in the cytosol. Under normal aerobic condition, pyruvate enters the
mitochondria for oxidative phosphorylation. In cases of hypoxia, mitochondria damages or
elevated energy demand, however, pyruvate can also be reduced to lactate to facilitate NAD+
regeneration as a result of anaerobic respiration, or to compensate for the inability of MAS to
keep pace with cytosolic NAD+ demand (Kane, 2014).
As is shown in Figure 14, the HF group presented with a considerably higher ratio of
malate/aspartate, glycerol-3P/DHAP and lactate/pyruvate, indicating that the relative content of
the electron carriers, malate, G3P and lactate, are elevated. As such, the HF group is in a
relatively oxidized cellular state with respect to the control. In contrast, the 1% and 3%
supplemented diets were able to lower each of these ratios in a does dependent manner.
Interestingly, the 5% group exhibited elevated levels of all three ratios comparable to or even
higher than the HF group. Further investigation of HIF-1α or mitochondrial electron transport
chain complexes needs to be completed in order to determine the exact cause behind the latter
results as they are the indicators for possible hypoxia and mitochondria damages, respectively.

Figure 14 Ratios of three metabolite redox couples among five diet groups. Values are shown as the means ± SEM, n=11. Statistical analysis ANOVA and
Tukey’s multiple comparison was conducted (***p≤0.001).
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ii. Effects of GS-CL supplements on HF stressors: key carbon metabolic pathways
An overview of global changes caused by diet and GS-CL supplements is illustrated by
PLS-DA based on all the metabolite changes (Table 3) collected from all five groups in both 2D
and 3D score plot (Figure 15). The control and HF group are clearly separated with the 1% group
positioned in the middle, indicating a protective ability of GS-CL. The 3% group scatters across
1% and control group, representing the possibility of complete protection. Lastly, the 5% group is
clustered further away from both the 1% and 3% groups but partially overlaps with HF group,
further indicating that higher doses of GS-CL are less effective in modulating energy metabolism
caused by a HF diet.
The three GS-CL supplement groups were analyzed via targeted metabolomics and
compared with both HF and control groups using an OPLS-DA approach (shown in appendix),
which in turn were summarized, as depicted in Figure 16. For the 1% GS-CL, the majority of
elevated TCA metabolites caused by the HF diet were reduced back to the range of control group,
i.e., malate (from 0.349 ± 0.041 µMol/g to 0.192 ± 0.027 µMol/g), fumarate (from 0.098 ± 0.011
µMol/g to 0.044 ± 0.007 µMol/g), and succinate (from 1.015 ± 0.488 µMol/g to 0.370 ± 0.128
µMol/g). It must be noted however, that citrate was not affected by the 1% GS-CL supplement. In
addition, the 1% supplement was not able to stop the anaplerosis flow from pyruvate and amino
acids caused by the HF diet. Pyruvate continued to decrease from 0.031 ± 0.006 µMol/g in HF
group to 0.023 ± 0.002 µMol/g, while all the amino acids measured were even lower for 1%
group compared to the HF animals. The anaplerosis flow for the 1% group is most likely slower
than HF group as 3PG, GA3P and G1P are all lower, while PEP maintained the same level as HF
group. In addition, the net content of acetyl-CoA (0.015 ± 0.000 µMol/g) is significantly lower
than both control (0.032 ± 0.002 µMol/g) and HF groups (0.031 ± 0.003 µMol/g), implying that
cells are still relying on fatty acid β oxidation as the main and slow energy source. Interestingly,
glycerol-3-phosphate (G3P) decreased for the 1% group, indicating that the supplement may have
the ability to restrict de novo triglyceride synthesis. These results concurs with the decreased

Figure 15 PLS-DA score plot for five treatment groups. (A) 2D score plot (two components, component 1 22.4%, component 2 10.1%). (B) 3D score plot (three
components, component 1 22.4%, component 2 10.1%, component 3 8.5%). Each point represents one biological observation.
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plasma triglycerides demonstrated by Althwab (2016). Specifically, the plasma triglyceride levels
were reduced by 35% in hamsters fed with 1% red GS-CL supplemented HF diets compared with
HF diet alone (Althwab, 2016).
By increasing the GS-CL supplement to 3%, the beneficial effects became more evident.
Not only were the TCA metabolites malate (0.227 ± 0.025 µMol/g), fumarate (0.055 ± 0.008
µMol/g) and succinate (0.429 ± 0.214 µMol/g) as low as that of the 1% and control diets, but
gluconeogenesis and anaplerosis flow slowed down prominently as well (Figure 16). Although
pyruvate (0.024 ± 0.002 µMol/g) for the 3% group remained as low as 1% group, many of the
amino acids were considerably higher than the HF group. Still, others, such as tyrosine, glutamate
and glutamine, were restored completely similar to the low fat diet. Moreover, the glycolytic
metabolites, 3PG, GA3P and G1P, decreased significantly to the level of the control group. Also
G3P continued to decline in 3% group, suggesting a lasting restraining effect on triglyceride
synthesis. Finally, acetyl-CoA (0.019 ± 0.001 µMol/g) started to recover in 3% group. Combined
with slightly elevated citrate, these results indicate that the energy source begins to switch from
fatty acid β oxidation back to glucose when a HF diet is consumed in the presence of 3% (w/w)
GS lipid diet.
The 5% diet provides interesting and unexpected metabolic differences to both the 1%
and 3% diets. Similar to the two lower GS-CL supplement doses, the 5% diet was able to sustain
lower TCA metabolites, i.e., malate (0.208 ± 0.024 µMol/g), fumarate (0.060 ± 0.010 µMol/g)
and succinate (0.124 ± 0.044 µMol/g). This diet also improved most of the amino acids levels
relative to the 1% group. Some amino acids, such as alanine, serine and glycine, were restored
completely, which was not achieved by the 3% group. Interestingly, however, the glycolytic
metabolites 3PG and GA3P continued to decline with the noticeable exception of PEP (0.031 ±
0.003 µMol/g). The level of this intermediate was the highest among all five groups, suggesting
accumulation of PEP. Moreover, lactate and G3P both spiked in 5% group, indicating that the cell
is routing pyruvate toward lactate instead of the TCA cycle while directing the glycolytic sugar
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phosphates toward triglyceride synthesis. In addition, acetyl-CoA (0.013 ± 0.001 µMol/g)
reversed its upward trend exerted by the 3% diet, but rather was the lowest among the five
groups. Based on this data, the 5% diet restricted the carbon flow from entering the TCA cycle,
and channeled it towards lactate and triglycerides synthesis.
Overall, the 3% supplement diet was able to attenuate the damage on carbohydrate
metabolism inflicted by HF diet with most of its metabolites approach values exhibited by the
control group. The 3% diet was also able to stop the gluconeogenesis and anaplerosis from
pyruvate and amino acids, motivated the TCA cycle and reduced the reliance of the cells on fatty
acids. On the other hand, the 1% supplement diet was able to maintain a motivated TCA cycle,
although the gluconeogenesis and anaplerosis was not halted. The 1% diet was not able to
completely restore the deteriorating effect of a HF diet, but it did halt some of the changes in
central metabolism. Lastly, the 5% GS-CL terminated anaplerosis from amino acids. However,
carbon flow was restricted from entering the TCA cycle, which may due to the possible
mitochondria damages caused by the increased fat burden of the 5% lipid supplement. Instead,
this diet directed the carbon flow toward lactate and triglyceride synthesis.

III.

Specific aim 2: GS-CL supplements modulate short chain fatty acid
profile produced by gut microbiota
Short chain fatty acids (SCFA) are volatile fatty acids produced by gut microbiota in

colon as fermentation products. These molecules are characterized by containing fewer than six
carbons, existing in straight and branched-chain formation, among which, acetate (C2), propionate
(C3) and butyrate (C4) are the most abundant, representing 90% of the SCFA present in the colon
(Ríos-Covián, et al., 2016). The biological effects of SCFA was reviewed in detailed by RíosCovián et al. (2016). More specifically, both butyrate and propionate have been reported to exert
prominent effects in reducing inflammation and other diet-induced stressors, such as HF diets.

Figure 16 The impact of GS-CL on central carbon metabolism. Values are shown as the means ± SEM, n=11. Statistical analysis ANOVA and
Tukey’s multiple comparison was conducted (***p≤0.001, **p≤0.01, *p≤0.05).
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For example, Jakobsdottir et al. (2013) demonstrated that a HF diet reduces the formation of
SCFA on the whole and butyrate in particular in rats. In addition, the abundance of acetateproducing bacteria was increased in response to chronic HF diet consumption (Lecomte, et al.,
2015).
The diet can also positively affect the gut microbiota composition and activity, and
therefore the profile of synthesized SCFA (Brüssow & Parkinson, 2014). One such diet consists
of high fiber and low fat diet, which has been characterized by higher levels of fecal SCFA
(Cuervo, Salazar, Ruas-Madiedo, Gueimonde, & González, 2013). In the current experiment, the
change in gut microbiota profile has yet to be determined, but the concentration of three most
abundant SCFA was analyzed in five diet groups. The amount of acetate in HF and 5%
supplement groups increased dramatically, over 10-fold higher compared to the control, 1% and
3% supplement groups (Figure 17A). Although butyrate was not detected in HF and 5%
supplement groups, 1% and 3% supplement groups did produce a dose-dependent recovery in
butyrate. Still, the latter two dosages were not able to completely remediate the effects caused by
the HF diet as butyrate levels were higher in the control group (Figure 17B). For propionate, all
HF groups with or without GS-CL supplement were lower compared to the control group. It is
further noticeable that the 5% group presented with even lower levels of propionate than the HF
group (Figure 17C).
Based on the data, the 3% GS-CL supplement demonstrated the optimal protection of the
SCFA profile against HF-induced stress followed by the 1% supplement. The 5% supplement
group did not show any improvement when compared to HF group. This trend is also exemplified
in the acetate: propionate ratio (Figure 17D). As acetate is a substrate involved in cholesterol
synthesis via acetyl-CoA, it is generally preferable to have a low acetate: propionate ratio
(Jakobsdottir, Xu, Molin, Ahrné, & Nyman, 2013). The 1% and 3% supplement groups showed a
low acetate: propionate ratio comparable to the control group whereas 5% supplement group is
comparable to the HF group.
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Figure 17 Effect of GS-CL on short chain fatty acid profile. Values are shown as the means ± SEM, n=11. Statistical
analysis ANOVA and Tukey’s multiple comparison was conducted (***p≤0.001).
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IV.

Specific aim 3: Characterization of red grain sorghum (sorghum
bicolor) whole kernel crude lipid

A. Characterization of red GS-CL
Determination of the whole kernel red GS-CL showed yields of 0.2-0.4% on a dry weight
basis, which is similar to that reported by Hwang et al. (2004). Christiansen (2008) produced a
higher yield (0.6%), but a solvent to solid ratio of 3:1 was employed compared to the 1:1 ratio
used in this study, which may have caused the yield variability. For example, total lipid yield is
influenced by the method of its extraction (Christiansen K. , Weller, Schlegel, & Dweikat, 2008).
However, for GS, the difference of extraction method is only significant for the ground GS and
GS-DDGS, indicating that the lipid yield of whole kernel GS is not affected by the method of
extraction (Leguizamón, Weller, Schlegel, & Carr, 2009). In addition, Leguizamón (2009)
showed that the form of GS is substantially affects lipid yields. Lipid yields obtained of GSDDGS was higher lipid compared to either ground or whole kernel GS as the non-starch
compounds are concentrated after fermentation. Although ground GS does not produce as much
lipid as GS-DDGS, ground GS yields higher amount of lipid compared to the whole kernel GS
due to increased surface area. Indeed, Hwang et al. (2004) reported a lipid yield of 0.5-0.6% from
GS-DDG, much higher than the yield of 0.2-0.3% from GS whole kernel.
Further characterization of the red whole kernel lipid, as depicted by TLC (Figure
18),showed the presence of monoacylglycerols, diacylglycerols, triacylglycerols, fatty acids, fatty
aldehydes, fatty alcohols (policosanols), free sterols (phytosterols), wax/steryl easters and
hydrocarbons. These results concur with the TLC analysis reported by Carr et al. (2005).
Among TLC shown lipid categories, phytosterols and policosanols are of particular
interest due to their many health benefiting effects, including cholesterol management, improving
blood lipid profile and anti-cancer (Carr, Ash, & Brown, 2010) (Awad & Fink, 2000) (GouniBerthold & Berthold, 2002). For the whole kernel red GS-CL, phytosterols were present at 4.93 ±
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Figure 18 The simple lipid profile of GS-CL analyzed by thin layer chromatography (TLC). Lipid was spotted on silica
plate and developed with hexane: diethyl ether: acetic acid (85:15:2, by volume). The plate was visualized by
submerged briefly in 10% cupric sulfate, 8% phosphoric acid solution, air-drying in a chemical fume hood before
charring in an oven at 165°C for 10min.
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0.05 mg/g lipid total phytosterols with β-sitosterol being the most abundant (58.7%), followed by
campesterol (24.3%) and stigmasterol (16.9%) (Table 3). These results were slightly higher than
the 3.48 mg/g lipid and 2.98 mg/g lipid reported by Carr et al. (2005) and Leguizamón et al.
(2009), respectively. In addition, the prevalence of these three phytosterols is supported by a
study performed by Leguizamón et al. (2009). However, Christiansen (2007) reported that
stigmasterol was the most abundant phytosterol in whole kernel lipid extracts of nine different
parent lines of GS, which was probably due to the co-elution between stigmasterol and
triacontanol (C30). In addition, extraction time and method (Winkler, Rennick, Eller, & Vaughn,
2007), and hydrolysis and saponification during sample preparation (Piironen, Toivo, & Lampi,
2002) can also affect the yield of phytosterols.
The level of total policosanols in red GS-CL was 15.61 ± 0.6 mg/g with octacosanol (C28)
(50.9%) and hexacosanol (C26) (40.4%) being the major components. It must be emphasized that
the extracts obrained from the red whole kernel GS contained higher policosanols compared to
8mg/g lipid measured by Carr et al. (2005), but lower compared to 18.82 mg/g lipid measured by
Leguizamón et al. (2009). Although Leguizamón et al. (2009) also reported high levels of
octacosanol (51.5%) and hexacosanol (24.5%), they detectedonly 21.2% of triacontanol (C30) and
very little of dotriacontanol (2.8%). Similar to that of the total lipid, the yield of policosanols are
much higher from GS-DDG than that of GS whole kernel (Hwang, Weller, Cuppett, & Hanna,
2004). Policosanols, mostly long-chain fatty acids, tend to remain intact during the ethanol
fermentation process, hence are likely concentrated in DDG form. Interestingly, Hwang et al.
(2004) also reported fairly high percentage of triacontanol (C30, 40-43%) yield.
Similar to other cereal groups, triacylglycerols is one of the most abundant lipid classes
present in whole kernel GS lipid extract (Lee, et al., 2011). Fatty acid analysis showed that
linoleic acid, oleic acid and palmitic acid are the predominant fatty acid classes in whole kernel
red GS-CL (Figure 19), together comprising up to 88.8% fatty acids. Carr et al. (2005) reported
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Table 3 Other composition of GS-CL.
Compound

Composition

Content

Total amount (mg/g lipid)

4.93 ± 0.05mg

β-Sitosterol

58.7%

Stigmasterol

16.9%

Campesterol

24.3%

Total amount (mg/g lipid)

15.61 ± 0.6mg

Hexacosanol (C28)

40.4%

Octacosanol (C26)

50.9%

Dotriacontanol (C32)

8.7%

Vitamin E2

As mg α-Tocopherol per g
lipid

0.068 ± 0.007mg

Carotenoids3

Total amount (µg/g lipid)

0.77 ± 0.04µg

Tannins4

As mg catechin per g lipid

0.278 ± 0.008mg

Phytosterols1

Policosanols1

1

Phytosterols and policosanols were determined by GC-FID as described by Leguizamón et al. (2009);
α-Tocopherols was analyzed by a spectrophotometer as described by Wong et al. (1988);
3
Carotenoids were determined by a spectrophotometer as described by Lichtenthaler & Buschmann (2001);
4
Tannins were determined by a spectrophotometer as described by Bhat et al. (2007).
2
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Palmitic Acid
(C16:0)
20%
Oleic Acid (C18:1)
35%

Steric Acid
(C18:0)
4%

Myristic Acid
(C14:0)
2%
Linolenic Acid
(C18:3)
2%

Palmitoleic Acid
(C16:1)
1%

Eicosanoic Acid
(C20)
1%

Linoleic Acid
(C18:2)
35%

Figure 19 The fatty acid profile of GS-CL. Fatty acids were analyzed by GC-FID after methylation as described by
Metcalfe et al. (1966). Percentage results from the cited compositional analyses are based on relative amounts.
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similar fatty acid composition of 17% palmitic acid, 35% oleic acid and 41% linoleic acid.
Christiansen (2006) noted that the lipid extract from ground GS contains more triacylglycerols
and diacylglycerols while whole kernel GS lipid extract contains more policosanols and
phytosterols. These results indicates that the health benefiting policosanols and phytosterols are
located mainly in the coating lipid covering the kernel surface.
In addition, micronutrients, including carotenoids, tocopherols and tannins were also
determined. The whole kernel GS-CL contains 0.068 mg/g lipid tocopherols, higher than the two
GS parent lines studied by Christiansen (2007) (21.9 mg and 57.7 mg per 100 g lipid). Also, the
red GS-CL contains 0.278 mg/g lipid tannins. Most of the GS cultivated in the US are tannin-free
due to their impact on the digestibility of many nutrients, but the selected red GS in this study
contains high tannin for the purpose of studying their part in the health benefiting effect of GS
lipid extract. Lastly, the whole kernel GS-CL contains 0.77 µg/g lipid carotenoids.
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B. Possible links between red GS-CL composition and its effects on central carbon
metabolism
The health promoting properties of bioactive compounds are connected to its
composition. The effects of red GS-CL on central carbon and energy metabolism discussed in
previous chapter reflect the combined effects of each component and the additive, synergistic or
antagonizing interactions among them. The major bioactive components in GS-CL, such as
phytosterols and policosanols, exert their own effect on central carbon metabolism, although
metabolic studies of these individual components remains limited as research on phytosterols and
policosanols are mainly focusing on its regulation on cholesterol and lipid metabolism (Carr, Ash,
& Brown, 2010) (Gouni-Berthold & Berthold, 2002). Nevertheless, Lee et al. (2015) showed that
barley sprout extracts (BSE) containing 5.74 mg/g policosanols affected hepatic glucose
metabolism in HF diet fed C57BL/6J mice model. The BSE supplement reduced fasting glucose
level by repressing hepatic gluconeogenesis genes, including fructose-1,6-biphosphatase and
pyruvate carboxylase (Lee, et al., 2015). Researchers further concluded that the activation of
AMPK was responsible for this repression. In addition, aloe vera phytosterol extracts suppressed
hyperglycemia and lowered both basal and fasting blood glucose levels in obese diabetic Zucker
rats (Misawa, et al., 2008). The phytosterol extracts repressed gluconeogenesis by lowering the
expressions of glucose-6-phosphatase and phosphoenolpyruvate carboxylase (PEPCK) and
promoted glycolysis by increasing the mRNA level of glycolysis enzyme glucokinase (GK)
(Misawa, et al., 2012). This beneficial effects of phytosterols in glucose metabolism can also be
traced back to its role in activating AMPK (Hwang, et al., 2008).
In the current study, gluconeogenesis caused by HF diet was partially mitigated by GSCL, especially in 3% GS-CL supplement group. Although the gene expression of pyruvate
carboxylase and PEPCK, which catalyze the gluconeogenic conversion of pyruvate to OAA and
OAA to PEP, respectively, have yet to be measured in this study, the suppression on
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gluconeogenesis by 1% and 3% GS-CL was evident by an increase in pyruvate and an decrease in
PEP. In addition, decreases in GA3P and 3PG presented by the supplemented groups indicated
that the rate of glycolysis was partially restored by GS-CL. Kim and Park (2012) have showed
that sorghum ethanol extract increases the phosphorylation of AMPK in streptozotocin-induced
diabetic rats. It is therefore possible that the results in the current experiment is connected to the
policosanols and phytosterols in GS-CL, which regulate the key gluconeogenesis and glycolysis
enzymes by activating of AMPK.
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5.

Conclusion and future studies
Grain sorghum is a widely cultivated yet critically underutilized crop in the US. The

crude lipid located on the surface of the whole kernal is of particular interest due to its unique
phytochemical profile and beneficial regulatory effects on plasma and liver cholesterol and gut
microbiota. In order to explore its impact on cellular central carbon and energy metabolism, GSCL was supplemented to a HF diet in 1, 3 and 5% dosage and fed to a hamster model for 4 weeks
period in comparison to a normal control diet and a HF diet.
The HF diet alone caused severe impairment in the ability of a cell to generate energy and
disrupted cellular redox balance in hamster large intestine. The excessive fat supply forced the
cells to reprogram its central carbon metabolism to use fat instead of glucose as the major energy
source in order to accommodate excessive fat and compensate for the insufficient glucose supply.
Many of amino acids as well as pyruvate are depleted greatly substantially when a system is in a
gluconeogenesis state. These compounds thus enter the TCA cycle from different point, resulting
in accumulated TCA cycle intermediates and elevated glycolytic intermediates.
The GS-CL supplements was able to restore the ability of the cells to generate energy as
energy charges obtained from three GS-CL supplemented groups all increased significantly.
However, they were not able to completely restore the redox balance disrupted by the HF feeding
as GSH and NAD+ levels were as low as HF group. Yet slight upward trend in NAD+/NADH
and GSH/GSSG ratios occurred possibly showing a long term protective effect based on feeding
time or dosage levels. Multivariant analysis showed that the 3% supplement diet was the optimal
diet in terms of protecting against damages to central carbon metabolism inflicted by HF diet by
activating the TCA cycle and glycolysis as well as suppressing gluconeogenesis similar to that
exerted by a low fat diet. The 1% supplement diet was not able to suppress anaplerosis from
amino acids but gluconeogenesis was halted and the TCA metabolic rate increased. The 5%
supplement diet was able to suppress anaplerosis from amino acids and motivate the TCA cycle,
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but resulted in increasing gluconeogenesis, most likely due to contributing to the overall fat
content. As a result, carbon flow towards lactate and triglyceride synthesis increased. For SCFA
production in response to GS-CL dosage levels, the 5% supplemented diet performed similar to
the HF diet while the 1% and 3% supplemented diets produced SCFA levels similar levels to the
control diet.
Results obtained from the current study should be used as a stepping stone, upon which
new theories and hypothesis can be built. In this study, cellular energy generation was severely
impaired by the HF diet, resulting in a considerably low energy charge in that group. Cellular
redox balance was also disrupted by the HF diet presented by a significantly lower NAD/NADH
ratio. It is possible that the excessive fat from the HF diet accumulated in mitochondria for β
oxidation, which damages the electron transport chain, thereby reduces the ability of the cells to
generate energy and recycle NADH. Analysis regarding the activity of electron transport chain
needs to be performed. In addition, elevated TCA cycle intermediates fumarate and succinate in
the HF group could lead to HIF-1α protein accumulation. As a transcription factor, HIF-1α binds
to nuclear, signaling a pseudo hypoxic cellular response (Koivunen, et al., 2007) (Selak, et al.,
2005) and possibly initiate inflammation. Quantitative analysis of HIF-1α protein and proinflammatory cytokine NF-κB and TNF-α are needed in order to understand the mechanism.
Moreover, the impact of GS-CL on SCFA profile is not fully understood until microbiome study
is performed on the fecal samples collected from all five groups. The GS-CL probably regulated a
single or multiple species in the gut microbiome resulting in the changes shown in SCFA profile.
The metabolic impact of GS-CL can be traced back to its composition. The red GS-CL
used in this experiment contained high levels of phytosterols and policosanols, both of which
have shown promoting effects on glycolysis and suppressing effects on gluconeogenesis by
activating the AMPK in the cell (Lee, et al., 2015) (Misawa, et al., 2012). Moreover, it is possible
that the GS-CL improved cellular energy state through activating AMPK because improved
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energy state can be attributed to AMPK activation (Wang, et al., 2015) (Kang, et al., 2015). The
phosphorylation and activity of AMPK need to be analyzed in all five groups, which will assist
understanding how the GS-CL protect the cells against HF induced damages on central carbon
metabolism, the connection between its composition and function.
Lee (2013) fractioned white GS-CL into oil and wax, and determined that the
phytosterols and policosanols are present in the oil and wax fraction, respectively. Both fractions
were then administered to each HF diet hamster model. Metabolic analysis of the intestinal tissue
show different impacts exerted by the two fraction groups (Lee, 2013). Therefore, it is
recommended that red GS-CL can also be separated into oil and wax fractions to understand how
each may reprogram cellular central metabolism differently compared to either the red GS-CL or
white GS fractions. The possible synergistic, antagonizing or simple additive interactions
between the two fractions may well further our understanding towards this novel healthy
promoting extract.
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Figure 20A Effect of 1% GS-CL on metabolomics. (A)Score plot (upper, R2X=0.592, R2Y=0.993, Q2=0.946) and coefficient plot (lower) for HF and 1%
groups. Positive bars (± SEM) of coefficient plot donate metabolites significantly increased when diet switch from HF to HF+1%. (B)Score plot (upper,
R2X=0.67,R2Y=0.989,Q2=0.908) and coefficient plot (lower) for control and 1% groups. Positive bars (± SEM) of coefficient plot donate metabolites
significantly increased when diet switch from control to HF+1%.
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Appendix

Figure 21A Effect of 3% GS-CL on metabolomics. (A)Score plot (upper, R2X=0.393, R2Y=0.951, Q2=0.859) and coefficient plot (lower) for HF and 3% groups.
Positive bars (± SEM) of coefficient plot donate metabolites significantly increased when diet switch from HF to HF+3%. (B)Score plot (upper,
R2X=0.591,R2Y=0.983,Q2=0.848) and coefficient plot (lower) for control and 1% groups. Positive bars (± SEM) of coefficient plot donate metabolites significantly
increased when diet switch from control to HF+3%.
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Figure 22A Effect of 5% GS-CL on metabolomics. (A)Score plot (upper, R2X=0.616, R2Y=0.99, Q2=0.784) and coefficient plot (lower) for HF and 5% groups.
Positive bars (± SEM) of coefficient plot donate metabolites significantly increased when diet switch from HF to HF+5%. (B)Score plot (upper,
R2X=0.742,R2Y=0.997,Q2=0.951) and coefficient plot (lower) for control and 1% groups. Positive bars (± SEM) of coefficient plot donate metabolites
significantly increased when diet switch from control to HF+5%.
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